Intensive glucose control after allogeneic hematopoietic stem cell transplantation: A retrospective matched-cohort study

Bone Marrow Transplantation

Volumn 44, Issue 2, 2009, Pages 105-111

  Fuji, S ^a   Kim, S W ^a   Mori, S ^b   Kamiya, S ^b   Yoshimura, K ^b   Yokoyama, H ^a   Kurosawa, S ^a   Saito, B ^a   Takahashi, T ^a   Kuwahara, S ^b   Heike, Y ^a   Tanosaki, R ^a   Takaue, Y ^a   Fukuda, T ^a  

^a Department of Hematology and Stem Cell Transplantation ^*  (Japan)

^b NATIONAL CANCER CENTER HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE; INSULIN;

ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; BACTEREMIA; BLOOD GLUCOSE MONITORING; CLINICAL ASSESSMENT; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HORMONE RESPONSE; HUMAN; HYPOGLYCEMIA; INFECTION; INFECTION RATE; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TOTAL PARENTERAL NUTRITION;

ADOLESCENT; ADULT; AGED; BLOOD GLUCOSE; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LIVING DONORS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 68149129628     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2008.431     Document Type: Article

References (27)

1. Van den Berghe G, Wouters P, Weekwrs F, Verwaest C, Bruyninckx F, Schetz M et al. Intensive insulin therapy in the critically ill patients. N Engl J Med 2001; 345: 1359-1367.
2. Van den Berghe G, Wilmer A, Hermans G, Meersseman W, Wouters PJ, Milants I et al. Intensive insulin therapy in the medical ICU. N Engl J Med 2006; 354: 449-461.
3. Van den Berghe G, Wouters PJ, Bouillon R, Weekers F, Verwaest C, Schetz M et al. Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control. Crit Care Med 2003; 31: 359-366.
4. Krinsley JS. Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients. Mayo Clin Proc 2003; 78: 1471-1478.
5. Krinsley JS. Effect of an intensive glucose management protocol on the mortality of critically ill adult patients. Mayo Clin Proc 2004; 79: 992-1000.
6. Vogelzang M, Nijboer JM, van der Horst IC, Zijlstra F, ten Duis HJ, Nijsten MW. Hyperglycemia has a stronger relation with outcome in trauma patients than in other critically ill patients. J Traum 2006; 60: 873-877.
7. Ingels C, Debaveye Y, Milants I, Buelens E, Peeraer A, Devriendt Y et al. Strict blood glucose control with insulin during intensive care after cardiac surgery: Impact on 4-years survival, dependency on medical care, and quality-of-life. Eur Heart J 2006; 27: 2716-2724.
8. Jeschke MG, Klein D, Bolder U, Einspanier R. Insulin attenuates the systemic inflammatory response in endotoxemic rats. Endocrinology 2004; 145: 4084-4093.
9. Brix-Christensen V, Andersen SK, Andersen R, Mengel A, Dyhr T, Andersen NT et al. Acute hyperinsulinemia restrains endotoxin-induced systemic inflammatory response: An experimental study in a porcine model. Anesthesiology 2004; 100: 861-870.
10. Sheean PM, Freels SA, Helton WS, Braunschweig CA. Adverse clinical consequences of hyperglycemia from total parenteral nutrition exposure during hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2006; 12: 656-664.
11. Sheean PM, Braunschweig C, Rich E. The incidence of hyperglycemia in hematopoietic stem cell transplant recipients receiving total parenteral nutrition: A pilot study. J Am Diet Assoc 2004; 104: 1352-1360.
12. Fietsam Jr R, Bassett J, Glover JL. Complications of coronary artery surgery in diabetic patients. Am Surg 1991; 57: 551-557.
13. Ortiz A, Ziyadeh FN, Neilson EG. Expression of apoptosis-regulatory genes in renal proximal tubular epithelial cells exposed to high ambient glucose and in diabetic kidney. J Invest Med 1997; 45: 50-56.
14. Vanhorebeek I, De Vos R, Mesotten D, Wouters PJ, De Wolf-Peeters C, Van den Berghe G. Protection of hepatocyte mitochondrial ultrastructure and function by strict blood glucose control with insulin in critically ill patients. Lancet 2005; 365: 53-59.
15. Fuji S, Kim SW, Mori S, Fukuda T, Kamiya S, Yamasaki S et al. Hyperglycemia during the neutropenic period is associated with a poor outcome in patients undergoing myeloablative allogeneic hematopoietic stem cell transplantation. Transplantation 2007; 84: 814-820.
16. Saito AM, Kami M, Mori SI, Kanda Y, Suzuki R, Mineishi S et al. Prospective phase II trial to evaluate the complications and kinetics of chimerism induction following allogeneic hematopoietic stem cell transplantation with fludarabine and busulfan. Am J Hematol 2007; 82: 873-880.
17. Fuji S, Kim S, Fukuda T, Kamiya S, Kuwahara S, Takaue Y. Positive impact of maintaining minimal caloric intake above 1.0 × basal energy expenditure on nutritional status of patients undergoing allogeneic hematopoietic stem cell transplantation. Am J Hematol 2008; 84 63-64.
18. Muscaritoli M, Grieco G, Capria S, Iori AP, Rossi Fanelli F. Nutritional and metabolic support in patients undergoing bone marrow transplantation. Am J Clin Nutr 2002; 75: 183-190.
19. Fuji S, Kim SW, Fukuda T, Mori S, Yamasaki S, Morita-Hoshi Y et al. Pre-engraftment serum C-reactive protein (CRP) value may predict acute graft-versus-host disease and non-relapse mortality after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2008; 14: 510-517.
20. Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J et al. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant 1995; 15: 825-828.
21. Ali NA, O'Brien Jr JM, Dungan K, Phillips G, Marsh CB, Lemeshow S et al. Glucose variability and mortality in patients with sepsis. Crit Care Med 2008; 36: 2316-2321.
22. Van Cromphaut S, Wilmer A, Van den Berghe G. Management of sepsis. N Engl J Med 2007; 356: 1179-1181.
23. Krinsley JS, Grover A. Severe hypoglycemia in critically ill patients: risk factors and outcomes. Crit Care Med 2007; 35: 2262-2267.
24. Rayfield EJ, Ault MJ, Keusch GT, Brothers MJ, Nechemias C, Smith H. Infection and diabetes: The case for glucose control. Am J Med 1982; 72: 439-450.
25. Geerlings SE, Hoepelman AI. Immune dysfunction in patients with diabetes mellitus (DM). FEMS Immunol Med Microbiol 1999; 26: 259-265.
26. Rassias AJ, Marrin CA, Arruda J, Whalen PK, Beach M, Yeager MP. Insulin infusion improves neutrophil function in diabetic cardiac surgery patients. Anesth Analg 1999; 88: 1011-1016.
27. Losser MR, Bernard C, Beaudeux JL, Pison C, Payen D. Glucose modulates hemodynamic, metabolic, and inflammatory responses to lipopolysaccharide in rabbits. J Appl Physiol 1997; 83: 1566-1574.